Paper3544786
Short- and long-term effects of calcium entry blockers on the kidney.
Bauer JH and 1 other. Am J Cardiol, 1987. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Short- and long-term effects of calcium entry blockers on the kidney. Papers, record 3544786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3544786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Kidney | Major topic |
| Animals | |
| Body Fluids | |
| Diuresis | |
| Electrolytes | |
| Humans | |
| Renal Circulation | |
| Renin-Angiotensin System | |
| Time Factors |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17154643 | A review of calcium channel antagonists in the treatment of pediatric hypertension. | Paediatr Drugs | 2006 | https://conductscience.org/library/papers/17154643 | PubMed |
| 8299661 | Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo. | Eur J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8299661 | PubMed |
| 7827397 | Do calcium channel blockers have renal protective effects? | Drugs Aging | 1994 | https://conductscience.org/library/papers/7827397 | PubMed |
| 7533695 | Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents. | Drugs | 1994 | https://conductscience.org/library/papers/7533695 | PubMed |
| 7512464 | Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure. | Drugs | 1993 | https://conductscience.org/library/papers/7512464 | PubMed |
| 3154672 | Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154672 | PubMed |
| 3154671 | Renal protective effects of calcium antagonists? | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/3154671 | PubMed |
| 3154329 | Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154329 | PubMed |
| 2856470 | Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action. | Cardiovasc Drugs Ther | 1987 | https://conductscience.org/library/papers/2856470 | PubMed |
| 2657078 | Management of essential hypertension in the black patient: profiling as the initial approach to treatment. | J Natl Med Assoc | 1989 | https://conductscience.org/library/papers/2657078 | PubMed |
| 2278868 | Effects of calcium antagonists on the hypertensive kidney. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2278868 | PubMed |
| 2150190 | Renal effects of the new calcium channel blocking drug isradipine. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2150190 | PubMed |
| 2076410 | Renal effects of calcium entry blockers. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2076410 | PubMed |
| 1989744 | Calcium-channel blockers and anaesthesia. | Can J Anaesth | 1991 | https://conductscience.org/library/papers/1989744 | PubMed |
| 1958437 | The effect of nifedipine on the disposition of strontium gluconate used as a kinetic marker for calcium in healthy volunteers. | Br J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1958437 | PubMed |
| 1451221 | Treatment of intraoperative hypertension with enflurane, nicardipine, or human atrial natriuretic peptide: haemodynamic and renal effects. | Can J Anaesth | 1992 | https://conductscience.org/library/papers/1451221 | PubMed |
| 1283592 | Is renal protection with calcium antagonists possible? | Drugs | 1992 | https://conductscience.org/library/papers/1283592 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3544786
GET https://conductscience.org/api/papers/v1/3544786/authors